Multicenter randomised trial of two versus three courses of preoperative cisplatin and fluorouracil plus docetaxel for locally advanced oesophageal squamous cell carcinoma

Tomoki Makino(The University of Osaka), Takushi Yasuda(Osaka International Cancer Institute), Masahiko Yano(Nagoya Sangyo University), Masaaki Motoori(Osaka International Cancer Institute), Hiroshi Miyata(Osaka University), Yuichiro� Doki(Osaka Gakuin University), Makoto Yamasaki(The University of Osaka), Shinya Urakawa(Osaka Prefectural Medical Center), Koji Tanaka(Mie University), Taroh Satoh(Osaka University Hospital), Osamu Shiraishi(Kindai University), Kazumasa Fujitani(Osaka Prefectural Medical Center), Yutaka Kimura(Kansai Medical University), Hidetoshi Eguchi(Osaka Gakuin University), Motohiro Hirao(Osaka National Hospital), Keijiro Sugimura(Osaka International Cancer Institute), Kotaro Yamashita(The University of Osaka), Tomo Ishida(The University of Osaka), Atsushi Takeno(Kansai Rosai Hospital)
British Journal of Cancer
February 9, 2022
Cited by 40


Related Papers